Assessing ICD-11 gaming disorder in adolescent gamers by parental ratings: Development and validation of the Gaming Disorder Scale for Parents (GADIS-P).


Journal

Journal of behavioral addictions
ISSN: 2063-5303
Titre abrégé: J Behav Addict
Pays: Hungary
ID NLM: 101602037

Informations de publication

Date de publication:
07 Jan 2021
Historique:
received: 30 07 2020
revised: 04 10 2020
revised: 05 11 2020
accepted: 06 12 2020
pubmed: 8 1 2021
medline: 14 4 2022
entrez: 7 1 2021
Statut: epublish

Résumé

The addiction to digital games is associated with substantial impairments in daily functioning and adolescents are particularly at risk. Screening instruments for the new ICD-11 diagnosis Gaming Disorder (GD) are rare and only include self-ratings thus far. Since adolescents' insight might be limited due to young age or symptom denial, external ratings are essential. We therefore aimed to develop and validate the Gaming Disorder Scale for Parents (GADIS-P) in a representative sample of parents and young gamers. GADIS-P was developed as an adaptation of a recently published self-rating scale. It was validated in 800 parents and their frequently gaming children between 10 and 17 years with standardized questionnaires in an online survey. Item structure was investigated by confirmatory factorial analysis. Gaming time, pathological gaming according to DSM-5, emotional dysregulation, and academic performance were used to derive criterion validity. Accordance with self-ratings was determined. ROC-Analyses were computed to determine cut-off values. A presumed two-factorial structure of GADIS-P could be confirmed describing cognitive-behavioral symptoms and negative consequences. The instrument showed good to excellent internal consistency (Cronbach's α = 0.89-0.92, McDonald's ω = 0.92-0.95) and criterion validity with moderate to strong correlations regarding gaming behavior (r/ϱ = 0.35-0.76), excellent discriminatory power, and moderate accordance with the adolescents' self-ratings (kappa = 0.47-0.58). As the first successfully validated tool for the assessment of ICD-11 GD in adolescents by parental judgment, GADIS-P can make an important contribution to reliable GD screening in clinical and research settings.

Sections du résumé

BACKGROUND AND AIMS OBJECTIVE
The addiction to digital games is associated with substantial impairments in daily functioning and adolescents are particularly at risk. Screening instruments for the new ICD-11 diagnosis Gaming Disorder (GD) are rare and only include self-ratings thus far. Since adolescents' insight might be limited due to young age or symptom denial, external ratings are essential. We therefore aimed to develop and validate the Gaming Disorder Scale for Parents (GADIS-P) in a representative sample of parents and young gamers.
METHODS METHODS
GADIS-P was developed as an adaptation of a recently published self-rating scale. It was validated in 800 parents and their frequently gaming children between 10 and 17 years with standardized questionnaires in an online survey. Item structure was investigated by confirmatory factorial analysis. Gaming time, pathological gaming according to DSM-5, emotional dysregulation, and academic performance were used to derive criterion validity. Accordance with self-ratings was determined. ROC-Analyses were computed to determine cut-off values.
RESULTS RESULTS
A presumed two-factorial structure of GADIS-P could be confirmed describing cognitive-behavioral symptoms and negative consequences. The instrument showed good to excellent internal consistency (Cronbach's α = 0.89-0.92, McDonald's ω = 0.92-0.95) and criterion validity with moderate to strong correlations regarding gaming behavior (r/ϱ = 0.35-0.76), excellent discriminatory power, and moderate accordance with the adolescents' self-ratings (kappa = 0.47-0.58).
DISCUSSION AND CONCLUSIONS CONCLUSIONS
As the first successfully validated tool for the assessment of ICD-11 GD in adolescents by parental judgment, GADIS-P can make an important contribution to reliable GD screening in clinical and research settings.

Identifiants

pubmed: 33410767
doi: 10.1556/2006.2020.00105
pmc: PMC8969850
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

159-168

Références

Clin Psychol Rev. 2010 Mar;30(2):217-37
pubmed: 20015584
Cyberpsychol Behav Soc Netw. 2019 Dec;22(12):771-778
pubmed: 31755742
J Clin Med. 2019 Jun 28;8(7):
pubmed: 31261841
J Clin Med. 2020 Apr 02;9(4):
pubmed: 32252305
J Clin Epidemiol. 1990;43(1):87-91
pubmed: 2319285
Clin Psychol Rev. 2020 Apr;77:101831
pubmed: 32143109
Dtsch Arztebl Int. 2013 Jun;110(25):425-31
pubmed: 23840287
Psychol Assess. 2015 Jun;27(2):567-82
pubmed: 25558970
Cyberpsychol Behav Soc Netw. 2019 Apr;22(4):264-270
pubmed: 30801222
Front Psychiatry. 2019 Apr 29;10:273
pubmed: 31110482
World Psychiatry. 2019 Feb;18(1):3-19
pubmed: 30600616
Brain Struct Funct. 2016 Apr;221(3):1427-42
pubmed: 25573247
Biopsychosoc Med. 2019 Feb 14;13:3
pubmed: 30809270
Syst Rev. 2020 Apr 2;9(1):68
pubmed: 32241295
Acta Psychiatr Scand. 2015 Nov;132(5):327-34
pubmed: 25968656
Aust N Z J Psychiatry. 2020 Jul;54(7):707-718
pubmed: 31631668
Child Adolesc Psychiatry Ment Health. 2017 Apr 28;11:23
pubmed: 28465720
Sci Rep. 2018 Jul 4;8(1):10084
pubmed: 29973627
J Behav Addict. 2017 Dec 1;6(4):534-544
pubmed: 29280395
Int J Environ Res Public Health. 2019 Dec 06;16(24):
pubmed: 31817573
Scand J Psychol. 2015 Dec;56(6):726-35
pubmed: 26440139

Auteurs

Kerstin Paschke (K)

German Center for Addiction Research in Childhood and Adolescence (DZSKJ), University Medical Center Hamburg-Eppendorf (UKE), Martinistrasse 52, D-20246 Hamburg, Germany.

Maria Isabella Austermann (MI)

German Center for Addiction Research in Childhood and Adolescence (DZSKJ), University Medical Center Hamburg-Eppendorf (UKE), Martinistrasse 52, D-20246 Hamburg, Germany.

Rainer Thomasius (R)

German Center for Addiction Research in Childhood and Adolescence (DZSKJ), University Medical Center Hamburg-Eppendorf (UKE), Martinistrasse 52, D-20246 Hamburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH